Research graph
References from Multiparametric Whole-Body MRI Protocols in Contemporary Clinical Practice: Indications, Technical Considerations, and Emerging Applications. Local targets link to admitted publications; unresolved targets remain external evidence.
Whole-body MRI in musculoskeletal oncology: a comprehensive review with recommendations
10.1148/rycan.220107 · 2023 · External reference
Whole-body MR imaging: musculoskeletal applications
10.1148/radiol.2016142084 · 2016 · External reference
Comparison between whole-body MRI and Fluorine-18-Fluorodeoxyglucose PET or PET/CT in oncology: a systematic review
10.2478/raon-2013-0007 · 2013 · External reference
How I do it: using the Dixon method and fat-water imaging in musculoskeletal MRI
10.1148/radiol.250374 · 2026 · External reference
Whole-body magnetic resonance imaging: technique, guidelines and key applications
10.3332/ecancer.2021.1164 · 2021 · External reference
Whole-body imaging of multiple myeloma: diagnostic criteria
10.1148/rg.2019180096 · 2019 · External reference
Multiple myeloma: 2018 update on diagnosis, risk-stratification, and management
10.1002/ajh.25117 · 2018 · External reference
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
10.1016/s1470-2045(19)30309-2 · 2019 · External reference
Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS)
10.1148/radiol.2019181949 · 2019 · External reference
What’s new for clinical whole-body MRI (WB-MRI) in the 21st century
10.1259/bjr.20200562 · 2020 · External reference
Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response
10.1186/s40644-020-0293-6 · 2020 · External reference
Multiparametric MRI in the detection of clinically significant prostate cancer
10.3348/kjr.2017.18.4.597 · 2017 · External reference
Predictive role of diffusion-weighted whole-body MRI (DW-MRI) imaging response according to MY-RADS criteria after autologous stem cell transplantation in patients with multiple myeloma and combined evaluation with MRD assessment by flow cytometry
10.1002/cam4.4136 · 2021 · External reference
Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes
10.1016/j.crad.2015.06.087 · 2015 · External reference
ACR appropriateness Criteria® prostate cancer—pretreatment detection, surveillance, and staging
10.1016/j.jacr.2017.02.026 · 2017 · External reference
Rationale for modernising imaging in advanced prostate cancer
10.1016/j.euf.2016.06.018 · 2017 · External reference
Whole-body magnetic resonance imaging for prostate cancer assessment: current status and future directions
10.1002/jmri.27485 · 2022 · External reference
The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer
10.1038/s41585-022-00618-w · 2022 · External reference
The role of PSMA PET/CT in the primary diagnosis and follow-up of prostate cancer—a practical clinical review
10.3390/cancers14153638 · 2022 · External reference
METastasis reporting and data system for prostate cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate cancer
10.1016/j.eururo.2016.05.033 · 2017 · External reference
Metastatic diffusion volume based on apparent diffusion coefficient as a prognostic factor in castration-resistant prostate cancer
10.1002/jmri.27596 · 2021 · External reference
Value of whole-body magnetic resonance imaging using the MET-RADS-P criteria for assessing the response to intensified androgen deprivation therapy in metastatic hormone-naïve and castration-resistant prostate cancer
10.1016/j.euo.2024.10.009 · 2025 · External reference
Whole-body magnetic resonance imaging in myxoid liposarcoma: a useful adjunct for the detection of extra-pulmonary metastatic disease
10.1016/j.ejso.2015.12.011 · 2016 · External reference
Whole-body magnetic resonance imaging in myxoid liposarcoma: toward a new standard?
10.1016/j.mri.2025.110422 · 2025 · External reference
The role of whole-body magnetic resonance imaging in assessing extrapulmonary metastases in osteosarcoma staging and restaging: a pilot study
10.1097/rct.0000000000001455 · 2023 · External reference
Clinical impact of whole-body MRI in staging and surveillance of patients with myxoid liposarcoma: a 14-year single-centre retrospective study
10.1007/s00330-024-10752-1 · 2024 · External reference
Whole-body MRI for staging and follow-up of primary musculoskeletal tumours: a systematic review
10.1093/bjr/tqag009 · 2026 · External reference
What is the comparative ability of 18F-FDG PET/CT, 99mTc-MDP skeletal scintigraphy, and whole-body MRI as a staging investigation to detect skeletal metastases in patients with osteosarcoma and Ewing sarcoma?
10.1097/corr.0000000000001681 · 2021 · External reference
Whole-body magnetic resonance imaging in pediatric oncology - recommendations by the Oncology Task Force of the ESPR
10.1007/s00247-020-04683-4 · 2020 · External reference
The role of whole-body MRI in pediatric musculoskeletal oncology: current concepts and clinical applications
10.1002/jmri.27787 · 2024 · External reference
Sensitivity and specificity of whole-body MRI for the detection of pediatric malignancy
10.1097/mph.0000000000002575 · 2023 · External reference
Management of cancer during pregnancy: ASCO guideline
10.1200/jco-25-02115 · 2025 · External reference
Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study
10.1007/s00330-017-5126-z · 2018 · External reference
Society for Maternal-Fetal Medicine Consult Series #76: cancer in pregnancy
10.1002/pmf2.70221 · 2026 · External reference
Whole-body MRI in oncology: focus on 3D sequences in musculoskeletal oncology
2025 · External reference
Oncologically relevant findings reporting and data system (ONCO-RADS): guidelines for the acquisition, interpretation, and reporting of whole-body MRI for cancer screening
10.1148/radiol.2021201740 · 2021 · External reference
Whole-body magnetic resonance neurography-technique, current perspectives, and future directions
10.1016/j.mric.2025.03.002 · 2025 · External reference
Biochemical and imaging surveillance in germline <em>TP53</em> mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study
10.1016/s1470-2045(16)30249-2 · 2016 · External reference
Clinical value of multiparametric whole-body magnetic resonance imaging over whole-spine magnetic resonance imaging in patients with neurofibromatosis type I
10.1016/j.wneu.2017.09.066 · 2017 · External reference
Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1
10.1215/15228517-2008-011 · 2008 · External reference
Assessment of paraspinal neurogenic tumors with diffusion-weighted MR imaging
10.1007/s00586-017-5265-6 · 2018 · External reference
Anatomy-informed deep learning and radiomics for neurofibroma segmentation in whole-body MRI
10.1016/j.compmedimag.2025.102667 · 2025 · External reference
Peripheral enthesitis assessed by whole-body MRI in axial spondyloarthritis: distribution and diagnostic value
10.3389/fimmu.2022.976800 · 2022 · External reference
Development and validation of an OMERACT MRI whole-body score for inflammation in peripheral joints and entheses in inflammatory arthritis (MRI-WIPE)
10.3899/jrheum.181084 · 2019 · External reference
Radiological diagnosis of chronic recurrent multifocal osteomyelitis using whole-body MRI-based lesion distribution patterns
10.1016/j.crad.2019.02.021 · 2019 · External reference
Chronic recurrent multifocal osteomyelitis: comparison of whole-body MR imaging with radiography and correlation with clinical and laboratory data
10.1148/radiol.2523081335 · 2009 · External reference
Whole-body MR neurography: prospective feasibility study in polyneuropathy and Charcot-Marie-Tooth disease
10.1002/jmri.25293 · 2016 · External reference
High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study
10.1097/01.rli.0000262089.55618.18 · 2007 · External reference
Technical challenges and opportunities of whole-body magnetic resonance imaging at 3 T
10.1016/j.ejmp.2008.01.011 · 2008 · External reference
Whole-body magnetic resonance imaging in children – how and why? A systematic review
10.1007/s00247-020-04735-9 · 2021 · External reference
Whole-body MRI in children: current imaging techniques and clinical applications
10.3348/kjr.2015.16.5.973 · 2015 · External reference
Advances in pediatric body MRI
10.1007/s00247-011-2103-6 · 2011 · External reference
Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma
10.1007/s00256-009-0789-4 · 2010 · External reference
Fat-only Dixon: how to use it in body MRI
10.1007/s00261-022-03546-w · 2022 · External reference
Multiparametric whole-body MRI of patients with neurofibromatosis type I: spectrum of imaging findings
10.1007/s00256-024-04765-6 · 2025 · External reference
Whole-body MRI: detecting bone metastases from prostate cancer
10.1007/s11604-021-01205-6 · 2022 · External reference
Comparison of T2 Dixon and standard sagittal MRI sequences for evaluating lumbar spine degeneration
10.37185/lns.1.1.759 · 2024 · External reference
Whole-body MRI vs bone scintigraphy in the staging of Ewing sarcoma of bone: a 12-year single-institution review
10.1007/s00330-019-06132-9 · 2019 · External reference
Inter- and intra-observer repeatability of quantitative whole-body, diffusion-weighted imaging (WBDWI) in metastatic bone disease
10.1371/journal.pone.0153840 · 2016 · External reference
Combining deep learning and radiomics for automated, objective, comprehensive bone marrow characterization from whole-body MRI: a multicentric feasibility study
10.1097/rli.0000000000000891 · 2022 · External reference
AI-driven software for automated quantification of skeletal metastases and treatment response evaluation using whole-body diffusion-weighted MRI (WB-DWI) in advanced prostate cancer
10.1088/1361-6560/ae19c5 · 2025 · External reference
Whole-body MRI screening of average risk populations: promises and controversies
10.1002/jmri.70268 · 2026 · External reference
Focal lesions in whole-body MRI in multiple myeloma: quantification of tumor mass and correlation with disease-related parameters and prognosis
10.1007/s00117-017-0299-7 · 2018 · External reference
Accelerating whole-body diffusion-weighted MRI with deep learning-based denoising image filters
10.1148/ryai.2021200279 · 2021 · External reference
Impact of whole-body MRI in a general population study
10.1007/s10654-015-0101-y · 2016 · External reference
Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies
2019 · External reference
Multiple myeloma: 2018 update on diagnosis, risk-stratification, and management
10.1002/ajh.25117 · ExternalCitation · doi-reference
Predictive role of diffusion-weighted whole-body MRI (DW-MRI) imaging response according to MY-RADS criteria after autologous stem cell transplantation in patients with multiple myeloma and combined evaluation with MRD assessment by flow cytometry
10.1002/cam4.4136 · ExternalCitation · doi-reference
Whole-body MR neurography: prospective feasibility study in polyneuropathy and Charcot-Marie-Tooth disease
10.1002/jmri.25293 · ExternalCitation · doi-reference
Whole-body magnetic resonance imaging for prostate cancer assessment: current status and future directions
10.1002/jmri.27485 · ExternalCitation · doi-reference
Metastatic diffusion volume based on apparent diffusion coefficient as a prognostic factor in castration-resistant prostate cancer
10.1002/jmri.27596 · ExternalCitation · doi-reference
The role of whole-body MRI in pediatric musculoskeletal oncology: current concepts and clinical applications
10.1002/jmri.27787 · ExternalCitation · doi-reference
Whole-body MRI screening of average risk populations: promises and controversies
10.1002/jmri.70268 · ExternalCitation · doi-reference
Society for Maternal-Fetal Medicine Consult Series #76: cancer in pregnancy
10.1002/pmf2.70221 · ExternalCitation · doi-reference
Focal lesions in whole-body MRI in multiple myeloma: quantification of tumor mass and correlation with disease-related parameters and prognosis
10.1007/s00117-017-0299-7 · ExternalCitation · doi-reference
Advances in pediatric body MRI
10.1007/s00247-011-2103-6 · ExternalCitation · doi-reference
Whole-body magnetic resonance imaging in pediatric oncology - recommendations by the Oncology Task Force of the ESPR
10.1007/s00247-020-04683-4 · ExternalCitation · doi-reference
Whole-body magnetic resonance imaging in children – how and why? A systematic review
10.1007/s00247-020-04735-9 · ExternalCitation · doi-reference
Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma
10.1007/s00256-009-0789-4 · ExternalCitation · doi-reference
Multiparametric whole-body MRI of patients with neurofibromatosis type I: spectrum of imaging findings
10.1007/s00256-024-04765-6 · ExternalCitation · doi-reference
Fat-only Dixon: how to use it in body MRI
10.1007/s00261-022-03546-w · ExternalCitation · doi-reference
Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study
10.1007/s00330-017-5126-z · ExternalCitation · doi-reference
Whole-body MRI vs bone scintigraphy in the staging of Ewing sarcoma of bone: a 12-year single-institution review
10.1007/s00330-019-06132-9 · ExternalCitation · doi-reference
Clinical impact of whole-body MRI in staging and surveillance of patients with myxoid liposarcoma: a 14-year single-centre retrospective study
10.1007/s00330-024-10752-1 · ExternalCitation · doi-reference
Assessment of paraspinal neurogenic tumors with diffusion-weighted MR imaging
10.1007/s00586-017-5265-6 · ExternalCitation · doi-reference
Impact of whole-body MRI in a general population study
10.1007/s10654-015-0101-y · ExternalCitation · doi-reference
Whole-body MRI: detecting bone metastases from prostate cancer
10.1007/s11604-021-01205-6 · ExternalCitation · doi-reference
Anatomy-informed deep learning and radiomics for neurofibroma segmentation in whole-body MRI
10.1016/j.compmedimag.2025.102667 · ExternalCitation · doi-reference
Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes
10.1016/j.crad.2015.06.087 · ExternalCitation · doi-reference
Radiological diagnosis of chronic recurrent multifocal osteomyelitis using whole-body MRI-based lesion distribution patterns
10.1016/j.crad.2019.02.021 · ExternalCitation · doi-reference
Technical challenges and opportunities of whole-body magnetic resonance imaging at 3 T
10.1016/j.ejmp.2008.01.011 · ExternalCitation · doi-reference
Whole-body magnetic resonance imaging in myxoid liposarcoma: a useful adjunct for the detection of extra-pulmonary metastatic disease
10.1016/j.ejso.2015.12.011 · ExternalCitation · doi-reference
Rationale for modernising imaging in advanced prostate cancer
10.1016/j.euf.2016.06.018 · ExternalCitation · doi-reference
Value of whole-body magnetic resonance imaging using the MET-RADS-P criteria for assessing the response to intensified androgen deprivation therapy in metastatic hormone-naïve and castration-resistant prostate cancer
10.1016/j.euo.2024.10.009 · ExternalCitation · doi-reference
METastasis reporting and data system for prostate cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate cancer
10.1016/j.eururo.2016.05.033 · ExternalCitation · doi-reference
ACR appropriateness Criteria® prostate cancer—pretreatment detection, surveillance, and staging
10.1016/j.jacr.2017.02.026 · ExternalCitation · doi-reference
Whole-body magnetic resonance imaging in myxoid liposarcoma: toward a new standard?
10.1016/j.mri.2025.110422 · ExternalCitation · doi-reference
Whole-body magnetic resonance neurography-technique, current perspectives, and future directions
10.1016/j.mric.2025.03.002 · ExternalCitation · doi-reference
Clinical value of multiparametric whole-body magnetic resonance imaging over whole-spine magnetic resonance imaging in patients with neurofibromatosis type I
10.1016/j.wneu.2017.09.066 · ExternalCitation · doi-reference
Biochemical and imaging surveillance in germline <em>TP53</em> mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study
10.1016/s1470-2045(16)30249-2 · ExternalCitation · doi-reference
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
10.1016/s1470-2045(19)30309-2 · ExternalCitation · doi-reference
The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer
10.1038/s41585-022-00618-w · ExternalCitation · doi-reference
AI-driven software for automated quantification of skeletal metastases and treatment response evaluation using whole-body diffusion-weighted MRI (WB-DWI) in advanced prostate cancer
10.1088/1361-6560/ae19c5 · ExternalCitation · doi-reference
Whole-body MRI for staging and follow-up of primary musculoskeletal tumours: a systematic review
10.1093/bjr/tqag009 · ExternalCitation · doi-reference
High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study
10.1097/01.rli.0000262089.55618.18 · ExternalCitation · doi-reference
What is the comparative ability of 18F-FDG PET/CT, 99mTc-MDP skeletal scintigraphy, and whole-body MRI as a staging investigation to detect skeletal metastases in patients with osteosarcoma and Ewing sarcoma?
10.1097/corr.0000000000001681 · ExternalCitation · doi-reference
Sensitivity and specificity of whole-body MRI for the detection of pediatric malignancy
10.1097/mph.0000000000002575 · ExternalCitation · doi-reference
The role of whole-body magnetic resonance imaging in assessing extrapulmonary metastases in osteosarcoma staging and restaging: a pilot study
10.1097/rct.0000000000001455 · ExternalCitation · doi-reference
Combining deep learning and radiomics for automated, objective, comprehensive bone marrow characterization from whole-body MRI: a multicentric feasibility study
10.1097/rli.0000000000000891 · ExternalCitation · doi-reference
Whole-body MR imaging: musculoskeletal applications
10.1148/radiol.2016142084 · ExternalCitation · doi-reference
Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS)
10.1148/radiol.2019181949 · ExternalCitation · doi-reference
Oncologically relevant findings reporting and data system (ONCO-RADS): guidelines for the acquisition, interpretation, and reporting of whole-body MRI for cancer screening
10.1148/radiol.2021201740 · ExternalCitation · doi-reference
How I do it: using the Dixon method and fat-water imaging in musculoskeletal MRI
10.1148/radiol.250374 · ExternalCitation · doi-reference
Chronic recurrent multifocal osteomyelitis: comparison of whole-body MR imaging with radiography and correlation with clinical and laboratory data
10.1148/radiol.2523081335 · ExternalCitation · doi-reference
Whole-body imaging of multiple myeloma: diagnostic criteria
10.1148/rg.2019180096 · ExternalCitation · doi-reference
Accelerating whole-body diffusion-weighted MRI with deep learning-based denoising image filters
10.1148/ryai.2021200279 · ExternalCitation · doi-reference
Whole-body MRI in musculoskeletal oncology: a comprehensive review with recommendations
10.1148/rycan.220107 · ExternalCitation · doi-reference
Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response
10.1186/s40644-020-0293-6 · ExternalCitation · doi-reference
Management of cancer during pregnancy: ASCO guideline
10.1200/jco-25-02115 · ExternalCitation · doi-reference
Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1
10.1215/15228517-2008-011 · ExternalCitation · doi-reference
What’s new for clinical whole-body MRI (WB-MRI) in the 21st century
10.1259/bjr.20200562 · ExternalCitation · doi-reference
Inter- and intra-observer repeatability of quantitative whole-body, diffusion-weighted imaging (WBDWI) in metastatic bone disease
10.1371/journal.pone.0153840 · ExternalCitation · doi-reference
Comparison between whole-body MRI and Fluorine-18-Fluorodeoxyglucose PET or PET/CT in oncology: a systematic review
10.2478/raon-2013-0007 · ExternalCitation · doi-reference
Whole-body magnetic resonance imaging: technique, guidelines and key applications
10.3332/ecancer.2021.1164 · ExternalCitation · doi-reference
Whole-body MRI in children: current imaging techniques and clinical applications
10.3348/kjr.2015.16.5.973 · ExternalCitation · doi-reference
Multiparametric MRI in the detection of clinically significant prostate cancer
10.3348/kjr.2017.18.4.597 · ExternalCitation · doi-reference
Peripheral enthesitis assessed by whole-body MRI in axial spondyloarthritis: distribution and diagnostic value
10.3389/fimmu.2022.976800 · ExternalCitation · doi-reference
The role of PSMA PET/CT in the primary diagnosis and follow-up of prostate cancer—a practical clinical review
10.3390/cancers14153638 · ExternalCitation · doi-reference
Comparison of T2 Dixon and standard sagittal MRI sequences for evaluating lumbar spine degeneration
10.37185/lns.1.1.759 · ExternalCitation · doi-reference
Development and validation of an OMERACT MRI whole-body score for inflammation in peripheral joints and entheses in inflammatory arthritis (MRI-WIPE)
10.3899/jrheum.181084 · ExternalCitation · doi-reference
